UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061151
Receipt number R000069976
Scientific Title A prospective observational registry study in a convalescent rehabilitation ward to estimate minimal important change (MIC) anchored to a Global Rating Scale and to identify recovery trajectory classes in stroke patients
Date of disclosure of the study information 2026/04/20
Last modified on 2026/04/03 13:31:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study linking patient-perceived change with routine rehabilitation outcomes in convalescent stroke patients

Acronym

STRoKe-REC

Scientific Title

A prospective observational registry study in a convalescent rehabilitation ward to estimate minimal important change (MIC) anchored to a Global Rating Scale and to identify recovery trajectory classes in stroke patients

Scientific Title:Acronym

STRoKe-REC

Region

Japan


Condition

Condition

Stroke(ischemic stroke and intracerebral hemorrhage), convalescent phase

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate minimal important change (MIC) in routinely collected rehabilitation outcomes using a Global Rating Scale as an anchor, and to identify distinct recovery trajectory classes from monthly longitudinal data during inpatient convalescent rehabilitation, examining clinical characteristics and therapy-related factors (e.g., therapy time) associated with each class.

Basic objectives2

Others

Basic objectives -Others

Estimation of MIC and identification of recovery trajectory classes using observational registry data

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Global Rating Scale (7-point): patient-rated overall change at discharge compared with admission (time point: discharge)

Key secondary outcomes

BBS, gait speed, FAC, FMA-UE/LE, ARAT, motor/cognitive FIM, MMSE, NIHSS, BRS, knee extensor strength, grip strength, mRS (time points: admission, monthly, discharge). Recovery trajectory classes (latent class growth analysis) and MIC estimates anchored to GRS.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1) Diagnosed with ischemic stroke or intracerebral hemorrhage and admitted to a convalescent rehabilitation ward after acute care; 2) Routinely assessed outcomes defined in this study are available from admission through discharge; 3) Not opted out.

Key exclusion criteria

1) Primary assessments cannot be obtained due to medical reasons (e.g., severe complications, clinical deterioration); 2) Opt-out declared during the study period.

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Kitaji

Organization

Tokyo General Hospital

Division name

Department of Rehabilitation

Zip code

165-8906

Address

Egota 3-15-2, Nakano-ku, Tokyo

TEL

03-3387-5421

Email

yu.kitaji@mt.strins.or.jp


Public contact

Name of contact person

1st name Yu
Middle name
Last name Kitaji

Organization

Tokyo General Hospital

Division name

Department of Rehabilitation

Zip code

165-8906

Address

Egota 3-15-2, Nakano-ku, Tokyo

TEL

03-3387-5421

Homepage URL


Email

yu.kitaji@mt.strins.or.jp


Sponsor or person

Institute

Tokyo General Hospital

Institute

Department

Personal name



Funding Source

Organization

Self-funded (institutional resources)

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo General Hospital

Address

Egota 3-15-2, Nakano-ku, Tokyo

Tel

03-3387-5421

Email

yu.kitaji@mt.strins.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 26 Day

Date of IRB

2026 Year 03 Month 28 Day

Anticipated trial start date

2026 Year 05 Month 01 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a single-center prospective observational cohort registry. Consecutive stroke patients admitted to a convalescent rehabilitation ward between [May/2026] and [March/2029] will be included. Routine outcomes are collected at admission, monthly during hospitalization, and at discharge. A 7-point Global Rating Scale at discharge will be used as an anchor to estimate MIC for each outcome. Recovery trajectory classes will be identified using latent class growth analysis, and associations with baseline characteristics and therapy time will be examined. An opt-out approach will be used.


Management information

Registered date

2026 Year 04 Month 03 Day

Last modified on

2026 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069976